TRVN
Price:
$1.69
Market Cap:
$1.44M
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and...[Read more]
Industry
Biotechnology
IPO Date
2014-01-31
Stock Exchange
NASDAQ
Ticker
TRVN
According to Trevena, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 21.55M. This represents a change of 24.18% compared to the average of 17.35M of the last 4 quarters.
The mean historical Enterprise Value of Trevena, Inc. over the last ten years is 2.83B. The current 21.55M Enterprise Value has changed -23.91% with respect to the historical average. Over the past ten years (40 quarters), TRVN's Enterprise Value was at its highest in in the December 2015 quarter at 13.30B. The Enterprise Value was at its lowest in in the December 2022 quarter at -4835508.50.
Average
2.83B
Median
1.34B
Minimum
-8441539.50
Maximum
11.47B
Discovering the peaks and valleys of Trevena, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 214.04%
Maximum Annual Enterprise Value = 11.47B
Minimum Annual Increase = -2849.79%
Minimum Annual Enterprise Value = -8441539.50
Year | Enterprise Value | Change |
---|---|---|
2023 | 232.12M | -2849.79% |
2022 | -8441539.50 | -123.86% |
2021 | 35.38M | -79.37% |
2020 | 171.52M | -91.01% |
2019 | 1.91B | 146.20% |
2018 | 775.26M | -67.55% |
2017 | 2.39B | -68.96% |
2016 | 7.70B | -32.88% |
2015 | 11.47B | 214.04% |
2014 | 3.65B | -11.88% |
The current Enterprise Value of Trevena, Inc. (TRVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
86.35M
5-year avg
467.86M
10-year avg
2.83B
Trevena, Inc.’s Enterprise Value is greater than AcelRx Pharmaceuticals, Inc. (1.19M), less than Lipocine Inc. (27.02M), less than Verastem, Inc. (115.44M), greater than vTv Therapeutics Inc. (-11209960.00), greater than Nabriva Therapeutics plc (3.29M),
Company | Enterprise Value | Market cap |
---|---|---|
1.19M | $14.58M | |
27.02M | $32.57M | |
115.44M | $156.95M | |
-11209960.00 | $34.06M | |
3.29M | $4.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trevena, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Trevena, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Trevena, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Trevena, Inc. (TRVN)?
What is the 3-year average Enterprise Value for Trevena, Inc. (TRVN)?
What is the 5-year average Enterprise Value for Trevena, Inc. (TRVN)?
How does the current Enterprise Value for Trevena, Inc. (TRVN) compare to its historical average?